Hutch News

Hutch News

Stories tagged 'Michael Jensen'

Forum at Fred Hutch focuses on the hottest developments in cancer immunotherapy

Immune-based treatments move from the fringes to the spotlight

June 16, 2017 | By Susan Keown / Fred Hutch News Service

What's new in cancer immunotherapy? Five hot topics, from new combination therapies to cost.

View story >

Replenishing immune cells after remission

New approach, not yet tested in humans, aims to restore immune-powering B cells in cancer patients following successful CAR T-cell therapy

Oct. 17, 2016 | By Bill Briggs / Fred Hutch News Service

Scientists at Fred Hutch, Seattle Children’s Research Institute, and Technical University of Munich showed that activating a “kill switch” can turn off CAR T cells after doctors deem a cancer defeated, allowing normal B cells to again flourish.

View story >

Pediatric cancer specialist speaks Nov. 10

Seattle Children's Michael Jensen will present next Clinical Research Division immunotherapy series lecture 2-3 p.m. in Pelton

Nov. 7, 2011

Dr. Michael Jensen of Seattle Children's will present the next Clinical Research Division Immunotherapy Seminar Series lecture Thursday, Nov. 10, 2-3 p.m. in the Fred Hutchinson Cancer Research Center's Pelton Auditorium .

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.